D T Beattie - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D T Beattie

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Lancet (London, England)|April 15, 1995

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.

British Journal of Pharmacology|October 7, 2004

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoD T Beattie, J A M Smith, D Marquess, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisC W Rittershaus, D P Miller, L J Thomas, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Lancet (London, England)|April 15, 1995

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.

British Journal of Pharmacology|October 7, 2004

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoD T Beattie, J A M Smith, D Marquess, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisC W Rittershaus, D P Miller, L J Thomas, et al.

Pageof 5